Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Kent DM, Hayward RA.

JAMA. 2007 Sep 12;298(10):1209-12. No abstract available.

PMID:
17848656
2.

Outcome reporting bias in clinical trials.

Esposito E, Cipriani A, Barbui C.

Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):17-8. No abstract available.

PMID:
19378694
3.

[Interpretation of clinical studies].

Jahrmäker H.

Med Klin (Munich). 1995 Jan 15;90(1):45-52. Review. German. No abstract available.

PMID:
7885305
4.
5.

The sirens are singing: the perils of trusting trials stopped early and subgroup analyses.

Martin CM, Guyatt G, Montori VM.

Crit Care Med. 2005 Aug;33(8):1870-1. No abstract available.

PMID:
16096474
6.

The case against independent monitoring committees.

Harrington D, Crowley J, George SL, Pajak T, Redmond C, Wieand S.

Stat Med. 1994 Jul 15-30;13(13-14):1411-4. No abstract available.

PMID:
7973220
7.

Interpretation of clinical trial results.

Practice Committee of American Society for Reproductive Medicine.

Fertil Steril. 2008 Nov;90(5 Suppl):S114-20. doi: 10.1016/j.fertnstert.2008.08.037. Review.

PMID:
19007606
8.

Area between curves: what you see is not what you get.

Gonen M.

J Clin Oncol. 2008 May 1;26(13):2236; author reply 2236-7. doi: 10.1200/JCO.2007.15.6414. No abstract available.

9.

Sample size calculations for ordered categorical data.

Whitehead J.

Stat Med. 1993 Dec 30;12(24):2257-71. Erratum in: Stat Med 1994 Apr 30;13(8):871.

PMID:
8134732
10.

Ignorability and bias in clinical trials.

Heitjan DF.

Stat Med. 1999 Sep 15-30;18(17-18):2421-34.

PMID:
10474150
11.

Some practical aspects of the interim monitoring of clinical trials.

Simon R.

Stat Med. 1994 Jul 15-30;13(13-14):1401-9.

PMID:
7973219
12.

[Statistical tricks. Can a proband be minus 2 years old?].

Butenandt O.

MMW Fortschr Med. 2006 Feb 2;148(5):13. German. No abstract available.

PMID:
16518930
13.

[Statistics--lying, but correctly!].

Bias R.

Wien Med Wochenschr. 1996;146(4):87-8. German. No abstract available.

PMID:
8650945
14.

Data handling in cancer clinical trials-how we can minimize potential biases.

Sakamoto J, Teramukai S.

Jpn J Clin Oncol. 2002 Jan;32(1):1-2. No abstract available.

15.

The what, why and how of Bayesian clinical trials monitoring.

Freedman LS, Spiegelhalter DJ, Parmar MK.

Stat Med. 1994 Jul 15-30;13(13-14):1371-83; discussion 1385-9.

PMID:
7973217
16.

Data Monitoring Committees and early stopping guidelines: the Southwest Oncology Group experience.

Crowley J, Green S, Liu PY, Wolf M.

Stat Med. 1994 Jul 15-30;13(13-14):1391-9.

PMID:
7973218
17.

[What is power and why specifically 80%?].

Dubben HH, Beck-Bornholdt HP.

Med Klin (Munich). 1999 Apr 15;94 Suppl 2:5-7. German. No abstract available.

PMID:
10740392
18.

[What is p and why specifically 0.05?].

Beck-Bornholdt HP, Dubben HH.

Med Klin (Munich). 1999 Apr 15;94 Suppl 2:3-4. German. No abstract available.

PMID:
10740391
19.

[Statistics--lying, but properly!].

Bias R.

Wien Med Wochenschr. 1996;146(8):178-80. German. No abstract available.

PMID:
8767404
20.

Revisiting the relation between change and initial value: a review and evaluation by Yu-Kang Tu and Mark S. Gilthorpe, Statistics in Medicine 2006; DOI: 10.1002/sim.2538.

Funatogawa I, Funatogawa T.

Stat Med. 2007 Jul 20;26(16):3205-6; author reply 3206-8. No abstract available.

PMID:
17066371
Items per page

Supplemental Content

Write to the Help Desk